Volume | 0 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | Mínimo Máximo |
||||||
Minimo del Dia |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Invitae Corporation | NVTA | NYSE | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.0891 | 0.0891 |
Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
---|---|---|---|
0 | 0 | - | 0.081 - 1.66 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
- | 0 | US$ 0.0891 | USD |
Información Financiera Invitae Corporation NVTA
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
US$ 25.53M | - | - | - | -0.82 |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Invitae Corporation NVTA
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
06/3/2024 | 07:31 | Edgar (US Regulatory) | Form 8-K - Current report |
06/2/2024 | 16:07 | Edgar (US Regulatory) | Form 8-K - Current report |
30/1/2024 | 06:00 | PR Newswire (US) | Invitae Partners with BridgeBio Pharma to Harness Genetic.. |
29/1/2024 | 15:01 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
24/1/2024 | 15:34 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
22/1/2024 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
22/1/2024 | 06:00 | PR Newswire (US) | Invitae Completes Sale of Reproductive Health Assets to.. |
18/1/2024 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
21/12/2023 | 20:20 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
21/12/2023 | 20:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
14/12/2023 | 15:29 | Edgar (US Regulatory) | Form 8-K - Current report |
13/12/2023 | 15:07 | PR Newswire (US) | Invitae Divests Ciitizen Health Data Platform and Implements.. |
Histórico de Datos NVTA
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.6669 | 0.7639 | 0.081 | 0.3962079 | 9,718,459 | -0.5778 | -86.64% |
1 Year | 1.235 | 1.66 | 0.081 | 0.7445791 | 9,553,838 | -1.15 | -92.79% |
3 Years | 32.54 | 35.51 | 0.081 | 4.76 | 8,433,673 | -32.45 | -99.73% |
5 Years | 21.80 | 61.59 | 0.081 | 10.70 | 6,121,763 | -21.71 | -99.59% |